Analysis of the prognostic factor in the patients with locally invasive bladder cancer who underwent total cystectomy

Japanese Journal of Urology

Volumn 89, Issue 10, 1998, Pages 816-822

  Noguchi, Sumio ^a   Takase, Kazunori ^a   Kubota, Yoshinobu ^a   Uemura, Hiroji ^a   Saitoh, Kazuo ^a   Masuda, Mitsunobu ^a   Yao, Masahiro ^a   Hosaka, Masahiko ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Locally invasive bladder cancer; Survival rate; Total cystectomy

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE; VINCRISTINE;

ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREOPERATIVE TREATMENT; PROGNOSIS; TREATMENT OUTCOME;

EID: 0031739511     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol1989.89.816     Document Type: Article

References (19)

1. Pagano, F., Bassi, P., Galleti, T.P., Maneghini, A., Milani, C., Artibani, W. and Garbeglio, A. : Results of contemporary radical cystectomy for invasive bladder cancer : A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J. Urol., 145, 45-50, 1991.
2. Splinter, T.A.W., Scher, H.I., Denis, L., Bukowki, R., Simon, S., Klimberg, L, Soloway, M., Vogelzang, N.J., Tinteren, H.V., Herr, H. and European Organization for Research on Treatment of Cancer-Genitourinary Group : The prognotic value of the pathological response to combination chemotherapy before systectomy in patients with invasive bladder cancer. J Urol., 147, 606-608, 1992.
3. Sternberg, C.N., Arena, M.G., Carabresi, F., Carli, P.D., Platania, A., Zeuri, M., Giannarelli, D., Cancrini, A. and Pansadoro, V. : Neoadjuvant M-VAC (Methotrexate, Vin blastine, Doxorubicin, and Cisplatin) for infiltrating transitional cell carcinoma of the bladder. Cancer, 72, 1975-1982, 1993.
4. Schultz, P.K., Herr, H.W., Zhang, Z.F., Bajarin, D.F., Seidoman, A., Sarkis, A., Fair, W.R., Scherr, D., Bosl, G.J. and Scher, H.I. : Neoadjuvant chemotherapy for invasive bladder cancer : Prognostic factors for survival of patients treated with M-VAC with 5-year follow-up. J. Clin. Oncol., 12, 1394-1401, 1994.
5. Malmstrom, P.U., Rintala, E., Wahlqvist, R., Hellsten, S., Hannisdal, E. and members of the Nordic Cooperative Bladder Cancer Study Group : Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy : Nordic cytectomy trial I. J. Urol., 155, 1903-1906, 1996.
6. Logothetis, C., Swanson, D., Amato, R., Banks, M., Finn, L., Ayala, A., Ro, J., Babaian, R., Dinney, C., Ellerhorst, J., Hall, C. and Eschenbach, A.V. : Optimal delivery of perioperative chemotherapy : Preliminary results of a randomized, prospective, comparative trial of preoperative and postoperative chemotherapy for invasive bladder carcinoma. J. Urol., 155, 1241-1245, 1996.
7. Dreicer, R., Messing, E.M., Loehrer, P.J. and Trump, D.L. : Perioperative methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) for poor risk tranitional cell carcinoma of the bladder : An eastern cooperative oncology group pilot study. J. Urol., 144, 1123-1127, 1990.
8. Sternberg, C.N., Yagoda, A., Scher, H.I., Watson, R.C., Herr, N., Morse, M.J., Sogai, P., Vaughan, E.D. Jr., Blander, N., Weiserberg, L. R., Celler, N., Hollander, P.S., Lipperman, R., Fair, W.R. and Whitmore, W.F. Jr. : M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced tranitional cell carcinoma of the urothelium. J. Urol., 139, 461-469, 1988.
9. Noguchi, S., Kobota, Y., Miura, T., Shui, T. and Hosaka, M. : Use of methotrexate, vinblastine, adriamycin and cisplatin in combination with radiation and hyperthermia as neoadjuvant therapy for bladder cancer. Cancer Chemother. Pharmacol.. 30, 63-65, 1992.
10. Kubota, Y., Shuin, T., Miura, T., Nishimura, R., Fukushima, S. and Takai, S. : Treatment of bladder cancer with combination of hyperthermia. radiation and bleomycin. Cancer, 53, 199 -202, 1984.
11. Kubota, Y., Shuin, T., Miura, T., Moriyama, M., Fukushima, S., Shiozaki, H. and Oshima, H. : Combination chemotherapy for metastatic urinary bladder cancer with 5-FU, Vincristine, Bleomycin, Cyclophosphamide, Mitomycin and Methotrexate. Cancer Treat. Rep., 68, 1167 -1168, 1984.
12. Droller, M.J. : The controversial role of radiation therapy as adjunctive treatment of bladder cancer. J. Urol., 129, 897-903, 1983.
13. Skinner D.G. and Lieskovski, G. : Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J. Urol., 131, 1069-1072, 1984.
14. Gabrilove, J.L., Jakubowski, A., Scher, H., Sternberg, C.N., Wong, G., Grou, J., Yagoda, A., Fain, K., Moore, M.A.S., Clarkson, B., Oettgen, H.F., Alton, K., Welte, K. and Sousa, L. : Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell cacinoma of the urothelium. N. Engl. J. Med., 318, 1414-1422, 1988.
15. Noguchi, S., Kubota, Y., Shuin, T., Hosaka, M., Miura, T. and Kondoh, I. : Schedule-intensified M-VAC chemotherapy for advanced urothelial cancer with recombi nant human granulocyte colony stimulating factor (rhG-CSF). Int. J. Urol., 1, 140-142, 1994.